Arcutis Biotherapeutics Inc (ARQT)
9.33
+0.04
(+0.43%)
USD |
NASDAQ |
Jun 27, 10:25
Arcutis Biotherapeutics Research and Development Expense (Annual): 110.58M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 110.58M |
| December 31, 2022 | 182.44M |
| December 31, 2021 | 145.56M |
| December 31, 2020 | 115.31M |
| Date | Value |
|---|---|
| December 31, 2019 | 36.52M |
| December 31, 2018 | 17.94M |
| December 31, 2017 | 3.411M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
36.52M
Minimum
2019
182.44M
Maximum
2022
118.08M
Average
115.31M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Heron Therapeutics Inc | 55.90M |
| Marinus Pharmaceuticals Inc | 99.39M |
| Amgen Inc | 4.784B |
| Pfizer Inc | 10.68B |
| Agios Pharmaceuticals Inc | 295.53M |